[Results, after 3 to 6 months of treatment, of the intravenous use of a soluble derivative of ethionamide in therapy of pulmonary tuberculosis].
D000995:Antitubercular Agents / Q000628:therapy*; D005000:Ethionamide; D006801:Humans; D007275:Injections, Intravenous; D014397:Tuberculosis, Pulmonary
D000995:Antitubercular Agents; D005000:Ethionamide
ANTITUBERCULAR AGENTS/therapy